Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Bioxcel Therapeutics
Bioxcel Therapeutics
(BTAI)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Igalmi
Dexmedetomidine
2022-04-05
2032-2039
Pain
,
Premedication
,
Psychomotor agitation
,
Conscious sedation
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Dexmedetomidine
alcoholism
,
post-traumatic stress disorders
,
alcohol drinking
,
traumatic stress disorders
,
delirium
,
substance withdrawal syndrome
,
opioid-related disorders
,
dementia
,
psychomotor agitation
,
schizophrenia
,
bipolar disorder
,
psychotic disorders
,
psychotic affective disorders
,
mood disorders
Benzodiazepine
atopic dermatitis
,
dermatitis
,
eczema
,
type 2 diabetes mellitus
,
healthy volunteers/patients
,
tuberculosis
,
pulmonary tuberculosis
,
schizophrenia
,
diabetes mellitus
,
insulin resistance
Benzocaine
breast neoplasms
,
neoplasm metastasis
Gilvetmab
ovarian neoplasms
,
kidney neoplasms
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
hematologic diseases
,
myelomonocytic leukemia chronic
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
,
bone marrow diseases
,
syndrome
,
gastrointestinal stromal tumors
,
glioblastoma
,
multiple myeloma
,
plasma cell neoplasms
,
alveolar soft part sarcoma
,
chordoma
,
thymoma
,
microsatellite instability
,
thymus neoplasms
,
cutaneous malignant melanoma
,
neoplasms
,
carcinoma
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
triple negative breast neoplasms
,
hepatocellular carcinoma
,
renal cell carcinoma
,
liver neoplasms
,
breast neoplasms
,
lung neoplasms
,
lymphoma
,
ovarian epithelial carcinoma
,
sarcoma
,
squamous cell carcinoma of head and neck
,
anus neoplasms
,
small cell lung carcinoma
,
adenocarcinoma
,
squamous cell carcinoma
,
squamous cell neoplasms
,
mesothelioma
,
pancreatic ductal carcinoma
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
pancreatic neoplasms
,
esophageal squamous cell carcinoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
neuroendocrine tumors
,
malignant mesothelioma
,
urologic neoplasms
,
thyroid neoplasms
,
esophageal neoplasms
,
uterine cervical neoplasms
,
cholangiocarcinoma
,
unknown primary neoplasms
,
adenocarcinoma of lung
,
clear cell adenocarcinoma
,
carcinosarcoma
,
uveal neoplasms
,
adenomyoepithelioma
,
uveal melanoma
,
hematologic neoplasms
,
anaplastic thyroid carcinoma
,
neuroendocrine carcinoma
,
melanoma
,
skin neoplasms
Aglatimagene besadenovec
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
breast neoplasms
,
ovarian neoplasms
Talabostat
pancreatic neoplasms
,
prostatic neoplasms
,
small cell carcinoma
,
neuroendocrine tumors
,
pancreatic ductal carcinoma
Edodekin alfa
substance withdrawal syndrome
Globulin, immune
neoplasms
Mk3475
leukemia
,
hematologic diseases
,
b-cell chronic lymphocytic leukemia
,
bone marrow diseases
,
colorectal neoplasms
,
colonic neoplasms
,
colonic diseases
,
neoplasms
,
squamous cell carcinoma of head and neck
Bxcl501
alcoholism
,
post-traumatic stress disorders
,
alcohol drinking
,
traumatic stress disorders
,
substance withdrawal syndrome
,
opioid-related disorders
,
delirium
,
dementia
,
psychomotor agitation
,
schizophrenia
,
bipolar disorder
,
psychotic disorders
,
psychotic affective disorders
,
mood disorders
Bxcl701
pancreatic neoplasms
,
prostatic neoplasms
,
small cell carcinoma
,
neuroendocrine tumors
,
pancreatic ductal carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use